Skip to content
10-Q

Quarterly Report

Turning Point Therapeutics, Inc.

0000950170-21-003748

← back to feed
Filed
Nov 9, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 2, 2021 49.48M sh
Capex Q3 2021 · Sep 30, 2021 $2.04M
Capex Q3 2021 · Sep 30, 2020 $874K
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$99.73M
Operating Cash Flow restated Q3 2021 · Sep 30, 2020 −$49.35M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $404.2M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $554.1M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $312.28M
Stockholders Equity Q3 2021 · Sep 30, 2021 $1.02B
Stockholders Equity Q3 2021 · Jun 30, 2021 $1.07B
Stockholders Equity Q3 2021 · Mar 31, 2021 $1.1B
Stockholders Equity Q3 2021 · Dec 31, 2020 $1.11B
Stockholders Equity Q3 2021 · Sep 30, 2020 $701.59M
Stockholders Equity Q3 2021 · Jun 30, 2020 $710.83M
Stockholders Equity Q3 2021 · Mar 31, 2020 $381.71M
Stockholders Equity Q3 2021 · Dec 31, 2019 $404.35M
Current Liabilities Q3 2021 · Sep 30, 2021 $38.75M
Current Liabilities Q3 2021 · Dec 31, 2020 $24.39M
Current Assets Q3 2021 · Sep 30, 2021 $1.05B
Current Assets Q3 2021 · Dec 31, 2020 $1.13B
Total Assets Q3 2021 · Sep 30, 2021 $1.06B
Total Assets Q3 2021 · Dec 31, 2020 $1.14B
Sga Expense Q3 2021 · Sep 30, 2021 $18.22M
Sga Expense Q3 2021 · Sep 30, 2021 $55.39M
Sga Expense Q3 2021 · Sep 30, 2020 $11.33M
Sga Expense Q3 2021 · Sep 30, 2020 $59.76M
Rd Expense Q3 2021 · Sep 30, 2021 $48.89M
Rd Expense Q3 2021 · Sep 30, 2021 $134.8M
Rd Expense Q3 2021 · Sep 30, 2020 $32.21M
Rd Expense Q3 2021 · Sep 30, 2020 $79.14M
Net Income Q3 2021 · Sep 30, 2021 −$66.33M
Net Income Q3 2021 · Sep 30, 2021 −$158.1M
Net Income Q3 2021 · Jun 30, 2021 −$56.27M
Net Income Q3 2021 · Mar 31, 2021 −$35.5M
Net Income Q3 2021 · Sep 30, 2020 −$17.71M
Net Income Q3 2021 · Sep 30, 2020 −$109.92M
Net Income Q3 2021 · Jun 30, 2020 −$31.49M
Net Income Q3 2021 · Mar 31, 2020 −$60.72M
Operating Income Q3 2021 · Sep 30, 2021 −$66.65M
Operating Income Q3 2021 · Sep 30, 2021 −$159.36M
Operating Income Q3 2021 · Sep 30, 2020 −$18.54M
Operating Income Q3 2021 · Sep 30, 2020 −$113.9M
Revenue Q3 2021 · Sep 30, 2021 $460K
Revenue Q3 2021 · Sep 30, 2021 $30.83M
Revenue Q3 2021 · Sep 30, 2020 $25M
Revenue Q3 2021 · Sep 30, 2020 $25M